Ultragenyx Pharmaceutical (RARE) Institutional Ownership $35.41 -1.94 (-5.19%) Closing price 04:00 PM EasternExtended Trading$35.42 +0.01 (+0.01%) As of 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Ultragenyx Pharmaceutical (NASDAQ:RARE)CurrentInstitutional OwnershipPercentage97.67%Number ofInstitutional Buyers(last 12 months)192TotalInstitutional Inflows(last 12 months)$789.66MNumber ofInstitutional Sellers(last 12 months)126TotalInstitutional Outflows(last 12 months)$720.74M Get RARE Insider Trade Alerts Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RARE Institutional Buying and Selling by Quarter Ultragenyx Pharmaceutical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Bayforest Capital Ltd9,190$333K0.1%+192.3%0.010% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC232,360$8.41M0.0%+14.8%0.246% 5/16/2025 Woodline Partners LP268,462$9.72M0.1%-0.4%0.284% 5/16/2025 Great Lakes Advisors LLC13,311$482K0.0%-93.0%0.014% 5/16/2025 Fred Alger Management LLC524,637$19.00M0.1%+12.5%0.555% 5/16/2025 Goldman Sachs Group Inc.480,269$17.39M0.0%-13.3%0.508% 5/16/2025 Parkman Healthcare Partners LLC304,244$11.02M1.3%+203.8%0.322% 5/16/2025 Millennium Management LLC712,393$25.80M0.0%+2.2%0.754% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.61,778$2.24M0.0%-6.0%0.065% 5/16/2025 EFG Asset Management North America Corp.122,942$4.45M0.7%-11.8%0.130% Get the Latest News and Ratings for RARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ultragenyx Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Cinctive Capital Management LP77,261$2.80M0.2%+22.7%0.082% 5/16/2025 Cutter Capital Management LP379,303$13.74M6.0%-6.8%0.401% 5/16/2025 Alliancebernstein L.P.1,247,380$45.17M0.0%-23.4%1.319% 5/16/2025 AQR Capital Management LLC92,047$3.31M0.0%-67.2%0.097% 5/16/2025 Alyeska Investment Group L.P.1,495,351$54.15M0.2%+3.9%1.582% 5/16/2025 Adage Capital Partners GP L.L.C.2,149,000$77.82M0.1%+81.6%2.273% 5/16/2025 Alkeon Capital Management LLC1,685,729$61.04M0.1%-0.1%1.783% 5/15/2025 First Light Asset Management LLC632,033$22.89M2.6%-17.2%0.669% 5/15/2025 Vestal Point Capital LP500,000$18.11M1.3%-66.7%0.529% 5/15/2025 MPM Bioimpact LLC398,445$14.43M2.5%+1.9%0.421% 5/15/2025 PDT Partners LLC104,921$3.80M0.3%+114.7%0.111% 5/15/2025 Cubist Systematic Strategies LLC121,510$4.40M0.0%N/A0.129% 5/15/2025 Graham Capital Management L.P.79,476$2.88M0.1%+34.4%0.084% 5/15/2025 Magnetar Financial LLC11,147$404K0.0%+64.4%0.012% 5/15/2025 Driehaus Capital Management LLC852,657$30.88M0.3%+2.8%0.902% 5/15/2025 Trexquant Investment LP268,666$9.73M0.1%+71.5%0.284% 5/14/2025 B. Metzler seel. Sohn & Co. AG30,038$1.09M0.0%+94.3%0.032% 5/14/2025 Rafferty Asset Management LLC88,812$3.22M0.0%-12.3%0.094% 5/14/2025 Comerica Bank7,352$266K0.0%+464.2%0.008% 5/14/2025 Walleye Capital LLC37,087$1.34M0.0%+657.3%0.039% 5/14/2025 Jump Financial LLC26,515$960K0.0%-76.5%0.028% 5/14/2025 AlphaQuest LLC10,919$395K0.0%+33.7%0.012% 5/14/2025 Price T Rowe Associates Inc. MD3,218,942$116.56M0.0%+28.1%3.405% 5/14/2025 Candriam S.C.A.728,017$26.36M0.2%+8.0%0.770% 5/14/2025 Capital Fund Management S.A.48,084$1.74M0.0%+40.5%0.051% 5/14/2025 EntryPoint Capital LLC10,982$398K0.2%+58.3%0.012% 5/14/2025 Hsbc Holdings PLC51,532$1.86M0.0%+8.5%0.055% 5/14/2025 Wellington Management Group LLP2,449,498$88.70M0.0%-0.3%2.591% 5/13/2025 Northern Trust Corp568,389$20.58M0.0%+7.5%0.601% 5/13/2025 Algert Global LLC130,320$4.72M0.1%+57.4%0.138% Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 5/13/2025 Aberdeen Group plc478,904$17.34M0.0%+51.0%0.507% 5/13/2025 Oak Ridge Investments LLC17,757$643K0.1%+2.3%0.019% 5/13/2025 E Fund Management Co. Ltd.8,300$301K0.0%+15.3%0.009% 5/13/2025 Russell Investments Group Ltd.103,822$3.76M0.0%+50.1%0.110% 5/12/2025 Knott David M Jr48,000$1.74M0.8%N/A0.051% 5/12/2025 Motley Fool Asset Management LLC84,473$3.06M0.2%+74.4%0.089% 5/12/2025 Motley Fool Wealth Management LLC149,596$5.42M0.3%-2.8%0.158% 5/12/2025 Nuveen LLC518,543$18.78M0.0%N/A0.552% 5/12/2025 Entropy Technologies LP7,549$273K0.0%N/A0.008% 5/12/2025 Invesco Ltd.1,213,282$43.93M0.0%-28.6%1.292% 5/12/2025 Covestor Ltd1,711$62K0.0%+86.8%0.002% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.44,901$1.63M0.0%+66.2%0.048% 5/12/2025 Swiss National Bank161,052$5.83M0.0%-1.3%0.172% 5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.6,342$230K0.0%+8.4%0.007% 5/9/2025 Headlands Technologies LLC1,623$59K0.0%N/A0.002% 5/9/2025 Deutsche Bank AG1,701,493$61.61M0.0%+0.5%1.812% 5/9/2025 Charles Schwab Investment Management Inc.593,121$21.48M0.0%-3.3%0.632% 5/9/2025 Vanguard Group Inc.9,996,226$361.96M0.0%-0.4%10.646% 5/9/2025 BIT Capital GmbH21,655$784K0.1%-27.5%0.023% 5/9/2025 Privium Fund Management B.V.249,804$9.05M2.4%-3.3%0.266% 5/9/2025 PNC Financial Services Group Inc.2,737$99K0.0%+231.4%0.003% 5/8/2025 US Bancorp DE2,857$103K0.0%-19.2%0.003% 5/8/2025 Natixis Advisors LLC23,506$851K0.0%-53.8%0.025% 5/8/2025 Bayforest Capital Ltd9,190$333K0.2%+192.3%0.010% 5/8/2025 XTX Topco Ltd31,780$1.15M0.1%+182.5%0.034% 5/8/2025 GSA Capital Partners LLP43,274$1.57M0.1%N/A0.046% 5/8/2025 Federated Hermes Inc.2,055,200$74.42M0.2%+0.3%2.189% 5/7/2025 Mackenzie Financial Corp18,658$676K0.0%+15.8%0.020% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 22,352$809K0.0%-2.3%0.024% 5/7/2025 TD Asset Management Inc138,484$5.02M0.0%+48.1%0.147% 5/7/2025 Skandinaviska Enskilda Banken AB publ 32,535$1.18M0.0%N/A0.035% 5/6/2025 ANTIPODES PARTNERS Ltd1,568$57K0.0%N/A0.002% 5/6/2025 Pinnacle Associates Ltd.143,375$5.19M0.1%-3.4%0.153% 5/6/2025 Pier 88 Investment Partners LLC22,370$810K0.2%+58.8%0.024% 5/6/2025 Universal Beteiligungs und Servicegesellschaft mbH134,253$4.86M0.0%+2.6%0.143% 5/6/2025 Y Intercept Hong Kong Ltd24,600$891K0.1%-7.8%0.026% 5/5/2025 Crestwood Advisors Group LLC100,730$3.65M0.1%-1.0%0.107% 5/5/2025 GW&K Investment Management LLC502,211$18.19M0.2%-1.4%0.535% 5/2/2025 Massachusetts Financial Services Co. MA502,023$18.18M0.0%+0.3%0.535% 5/1/2025 Emerald Advisers LLC516,228$18.69M0.8%-0.4%0.550% 5/1/2025 New York State Common Retirement Fund61,667$2.23M0.0%+5.3%0.066% 5/1/2025 Emerald Mutual Fund Advisers Trust340,975$12.35M0.9%+5.1%0.363% 5/1/2025 Xponance Inc.12,552$455K0.0%+2.8%0.013% 4/30/2025 M&T Bank Corp6,040$219K0.0%-6.3%0.006% 4/30/2025 China Universal Asset Management Co. Ltd.18,554$672K0.1%-5.2%0.020% 4/29/2025 Envestnet Asset Management Inc.28,258$1.02M0.0%-17.6%0.030% 4/29/2025 Bank of New York Mellon Corp696,161$25.21M0.0%-5.8%0.741% 4/29/2025 GF Fund Management CO. LTD.2,364$86K0.0%+21.9%0.003% 4/28/2025 Principal Financial Group Inc.88,068$3.19M0.0%-2.1%0.094% 4/28/2025 Teacher Retirement System of Texas22,369$810K0.0%-9.0%0.024% Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.4/28/2025 WCM Investment Management LLC202,213$7.65M0.0%+49.1%0.215% 4/25/2025 Peregrine Capital Management LLC169,467$6.14M0.2%+3.4%0.180% 4/25/2025 KBC Group NV3,696$134K0.0%-93.9%0.004% 4/23/2025 Oppenheimer Asset Management Inc.7,140$259K0.0%+19.7%0.008% 4/15/2025 Assenagon Asset Management S.A.215,890$7.82M0.0%+211.7%0.230% 4/15/2025 SG Americas Securities LLC237,573$8.60M0.0%+2,358.1%0.253% 4/15/2025 GAMMA Investing LLC747$27K0.0%+76.2%0.001% 4/14/2025 Wedge Capital Management L L P NC35,695$1.29M0.0%N/A0.038% 4/10/2025 Hennion & Walsh Asset Management Inc.61,160$2.22M0.1%-3.3%0.065% 4/7/2025 GAMMA Investing LLC27,049$979K0.0%+6,279.5%0.029% (Data available from 1/1/2016 forward) RARE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RARE shares? During the previous two years, 281 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical. The most heavily invested institutionals were Vanguard Group Inc. ($361.96M), Sands Capital Management LLC ($196.92M), State Street Corp ($147.99M), Price T Rowe Associates Inc. MD ($116.56M), RTW Investments LP ($109.32M), Clearbridge Investments LLC ($97.70M), and Wellington Management Group LLP ($88.70M).Learn more on RARE's institutional investors. What percentage of Ultragenyx Pharmaceutical stock is owned by institutional investors? 97.67% of Ultragenyx Pharmaceutical stock is owned by institutional investors. Learn more on RARE's institutional investor holdings. Which institutional investors have been buying Ultragenyx Pharmaceutical stock? Of the 239 institutional investors that purchased Ultragenyx Pharmaceutical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($1.77M), Norges Bank ($1.73M), Sands Capital Management LLC ($1.54M), RTW Investments LP ($1.48M), Adage Capital Partners GP L.L.C. ($965.92K), Millennium Management LLC ($957.69K), and Federated Hermes Inc. ($843.65K). How much institutional buying is happening at Ultragenyx Pharmaceutical? Institutional investors have bought a total of 29,716,553 shares in the last 24 months. This purchase volume represents approximately $1.30B in transactions. Which Ultragenyx Pharmaceutical major shareholders have been selling company stock? Of the 157 institutional investors that sold Ultragenyx Pharmaceutical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($2.89M), Vestal Point Capital LP ($2.05M), Alkeon Capital Management LLC ($1.33M), RTW Investments LP ($1.29M), Avoro Capital Advisors LLC ($1.15M), AQR Capital Management LLC ($1.11M), and Suvretta Capital Management LLC ($985.11K). How much institutional selling is happening at Ultragenyx Pharmaceutical? Institutional investors have sold a total of 21,316,446 shares in the last 24 months. This volume of shares sold represents approximately $962.05M in transactions. Related Companies Genmab A/S Major Shareholders Dr. Reddy's Laboratories Major Shareholders Viatris Major Shareholders Moderna Major Shareholders Ascendis Pharma A/S Major Shareholders Qiagen Major Shareholders Roivant Sciences Major Shareholders Revolution Medicines Major Shareholders Elanco Animal Health Major Shareholders Blueprint Medicines Major Shareholders This page (NASDAQ:RARE) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultragenyx Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultragenyx Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RARE Stock Free RARE Stock Alerts